Fulgent Genetics Correlations
FLGT Stock | USD 17.09 0.20 1.18% |
The current 90-days correlation between Fulgent Genetics and Caredx Inc is 0.22 (i.e., Modest diversification). The correlation of Fulgent Genetics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Fulgent Genetics Correlation With Market
Modest diversification
The correlation between Fulgent Genetics and DJI is 0.29 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Fulgent Genetics and DJI in the same portfolio, assuming nothing else is changed.
Fulgent |
Moving together with Fulgent Stock
Moving against Fulgent Stock
0.83 | BSX | Boston Scientific Corp | PairCorr |
0.82 | IRTC | iRhythm Technologies | PairCorr |
0.77 | FNA | Paragon 28 | PairCorr |
0.77 | MDT | Medtronic PLC | PairCorr |
0.72 | ALC | Alcon AG | PairCorr |
0.7 | SYK | Stryker | PairCorr |
0.69 | CVS | CVS Health Corp Aggressive Push | PairCorr |
0.63 | EHC | Encompass Health Corp | PairCorr |
0.59 | LUCD | Lucid Diagnostics | PairCorr |
0.57 | GDRX | Goodrx Holdings | PairCorr |
0.52 | MASI | Masimo | PairCorr |
0.47 | DXCM | DexCom Inc | PairCorr |
0.47 | LUNG | Pulmonx Corp | PairCorr |
0.46 | INMD | InMode | PairCorr |
0.33 | IART | Integra LifeSciences | PairCorr |
0.81 | SIBN | Si Bone | PairCorr |
0.8 | OPCH | Option Care Health | PairCorr |
0.76 | NVRO | Nevro Corp | PairCorr |
0.73 | TMCI | Treace Medical Concepts | PairCorr |
0.7 | NYXH | Nyxoah | PairCorr |
0.67 | SGRY | Surgery Partners | PairCorr |
0.67 | CCLDO | CareCloud | PairCorr |
0.62 | AMED | Amedisys | PairCorr |
0.58 | AMWL | American Well Corp | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Fulgent Stock performing well and Fulgent Genetics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Fulgent Genetics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ILMN | 1.94 | (0.66) | 0.00 | (0.84) | 0.00 | 3.38 | 15.07 | |||
TTOO | 8.95 | (0.09) | 0.00 | (0.14) | 0.00 | 17.14 | 130.00 | |||
A | 1.15 | (0.15) | 0.00 | (0.23) | 0.00 | 2.92 | 9.03 | |||
MTD | 1.23 | (0.04) | 0.00 | (0.12) | 0.00 | 2.34 | 8.60 | |||
WAT | 1.37 | 0.00 | 0.00 | (0.07) | 0.00 | 2.95 | 10.90 | |||
DHR | 1.11 | (0.12) | 0.00 | (0.32) | 0.00 | 2.19 | 12.14 | |||
TMO | 1.09 | 0.01 | 0.00 | (0.04) | 0.00 | 2.40 | 10.04 | |||
CRL | 1.68 | (0.15) | 0.00 | (0.36) | 0.00 | 3.86 | 11.78 | |||
CDNA | 3.02 | (0.04) | 0.00 | (0.09) | 0.00 | 5.88 | 19.59 |
Fulgent Genetics Corporate Management
Doreen Ng | Vice Compliance | Profile | |
DABMG FACMG | Chief Director | Profile | |
Paul Kim | Chief Officer | Profile | |
Natalie Prescott | General Officer | Profile | |
Lawrence MD | Chief Officer | Profile |